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Summary
Diabetes is a worldwide problem with polygenic etiology. Nevertheless 10% of patients with type 1 and 5% of patients with type 2 
diabetes have a monogenic form of this disease which has different treatment options and usually has fewer complications. We present 
a case analysis of a patient that has an unusual type of diabetes, presumably MODY, successfully treated with metformin.
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Abstract
Un caz de diabet zaharat al tinerilor cu debut la maturitate
Diabetul este o problemă mondială cu etiologie poligenică. Cu toate acestea 10% dintre pacienții cu tipul 1 şi 5% din pacienții cu diabet 
zaharat de tip 2 au o formă monogenică a acestei boli, care are diferite opțiuni de tratament şi, de obicei, are mai puține complicații. 
Prezentăm o analiză de caz al unui pacient care are un tip neobişnuit de diabet, probabil MODY, tratat cu succes cu metformin.
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Introduction
An analysis of 199 counties estimated that the number of 
adults with diabetes has doubled from 153 million in 1980 to 
347 million in 2008. By 2030 the number of individuals with 
diabetes worldwide may rise to 472 million. 80% of them will be 
in low and middle income countries. in some of these countries 
diabetic drugs and insulin are inaccessible or rather expensive 
which eventually affect the whole healthcare system [5].
Not all of these patients have the classical types of diabetes. 
Some of them may have monogenic forms with sometimes 
different presentations and better treatment options if they are 
diagnosed properly and in time.To date, several transcriptional 
factors and an enzyme are associated with maturity onset dia-
betes of the young (MoDY). Current data describes 11 types of 
MoDY [3]. These mutations are characterized by high level of 
penetrance. 95% of individuals that have MoDY will become 
diabetic or will have an altered glucose metabolism before the age 
of 55. Misdiagnosis of MoDY is a widespread problem. it is esti-
mated that about 5% of patients with T2D and about 10% of type 
1 diabetes (T1D) are misdiagnosed having actually MoDY [1]. 
A study performed by G. Thanabalasingham et al., 2012 
showed that 20 of 247 patients clinically labeled as T1D actually 
had HNF-1a or HNF-4a mutations. From 322 patients clinically 
labeled as T2D 80 had HNF-1a or HNF-4a mutations and 40 
had GCK mutation [4]. e.-J. Schiopu, 2011 reports that MoDY 
usually develops in 22% of cases due to GCK mutations, in 66% 
of cases due to mutations in transcription factors, less than 
1% in case of insulin gene (iNS) mutations, less than 1% due 
to carboxyl ester lipase mutation and about 11% due to other 
mutations sometimes of unknown etiology [2].
Material and Methods
in the case study we describe a patient with an unusual pre-
sentation of diabetes mellitus. The diagnosis was established us-
ing glucose tolerance test, glycated hemoglobin, blood biochemi-
cal analysis. Additional investigations included ultrasonography.
Results
A 15 year old female was diagnoses with diabetes (HbA1c 
9.1%; blood glucose 7,8 mmol/l; 16,2 mmol/l - 1 hour after meal; 
13,1 mmol/l – 2 hours after meal) which is clinically similar to 
type i diabetes. The mother and sister had a history of diabetes 
treated with insulin. Besides the altered glucose tolerance she had 
ii grade obesity (with Body Mass index 29,8 kg/m2), hyperlipide-
mia (with elevated cholesterol, lipoproteins), nontoxic (eutiroid) 
diffuse goiter. in a one year period she additionally developed 
diabetic nephropathy ii gr. and liver steatosis. Metformin was 
used as a treatment option in this case with good results though 
there were still alterations in glucose metabolism.
in this case genetical testing could reveal the exact mutati-
on of the gene and give us a better understanding of the disease 
and the possibility for better treatment options.
Discussions and conclusions
in Republic of Moldova there are approximately 60 thou-
sand diabetic patients, which mean that represents somewhere 
50% of the endocrine diseases. it means that there is a great 
possibility that not all diabetic patients receive the proper 
treatment. Some of them may need oral diabetic medication, 
others can live a proper life without any medication at all. 
Patients that receive insulin as drug of choice may have with 
time compromised β-cell function with a wide range of severe 
complications. Further investigation in this area can improve 
the possibilities for diagnosis and treatment of genetic diabetes, 
its complications and improve the live quality and expectancy 
in the country.
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